FDA Adverse Event Injury Summary report: N

SCULPTRA, POLY-L-LACTIC ACID

MDR report key: 3902307 · Received June 25, 2014

Report

Report Number
3009443653-2014-00217
Event Type
Injury
Date Received
June 25, 2014
Report Date
May 26, 2014
Product Code
LMH
PMA / PMN Number
P030050
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
KS
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

HEART DISEASE CONGENITAL, MATERNAL DRUGS AFFECTING FOETUS ASSESSED A SERIOUS AND UNASSESSABLE.

Description of Event or Problem · 1

THIS SPONTANEOUS CASE WAS RECEIVED ON (B)(4) 2014 FROM A CONSUMER AND CONCERNS A FETUS. THE PT'S MED HISTORY AND CONCOMITANT MEDICATIONS WERE NOT REPORTED. ON AN UNK DATE IN (B)(6) 2014, A FEMALE CONSUMER (AGE GROUP: ADULT) WAS APPLICATED WITH SCULPTRA. AFTER APPLICATION, SHE LEARNED THAT SHE WAS FOUR WEEKS INTO PREGNANCY. SHE HAD BEEN PRESCRIBED ANTIBIOTICS AND ANTI-INFLAMMATION AGENTS AFTER APPLICATION OF SCULPTRA. ON AN UNK DATE THE GYNECOLOGIST SUSPECTED FETAL HEART MALFORMATION. THE PT WAS (B)(6) AT THE TIME OF REPORT. THE PT'S DOCTOR EXPLAINED SCULPTRA DISINTEGRATED IN THE BODY AND CONSIDERED THERE WAS NO RISK AT PREGNANCY CAUSED BY SCULPTRA. THE PT DID NOT CONSENT ON LOCAL PRIVACY LAW SO NO FURTHER INFO IS AVAILABLE. FOR REFERENCE PURPOSES ONLY, THIS CASE HAS ALSO BEEN ASSIGNED THE FOLLOWING TRACKING NUMBERS: (B)(4) INOVA). FOLLOW UP REQUEST NOT SENT AS PT DID NOT PROVIDE CONSENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
370297 SCULPTRA, POLY-L-LACTIC ACID INJECTABLE DERMAL FILLER LMH

Patients

Seq Age Sex Outcome Treatment
1 FETUS Congenital Anomaly